147769-93-5: Repaglinide EP Impurity C
Repaglinide EP Impurity C / Repaglinide Related Compound A / Repaglinide BP Impurity C (CAS No: 147769-93-5) or (1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine, is dependent on the presence functioning v cells and glucose and Peak plasma concentrations are observed within 1 hour.
Additional information on CAS 147769-93-5
Catalogue No.
VE006549
CAS No.
147769-93-5
Molecular Formula
C16H26N2
Molecular Weight
246.39
Parent drug
Repaglinide
IUPAC Name
(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine
Synonyms
Repaglinide Related Compound A /Repaglinide BP Impurity C
References
Guardado-Mendoza, Rodolfo, et al. “State of the Art Paper the Role of Nateglinide and Repaglinide, Derivatives of Meglitinide, in the Treatment of Type 2 Diabetes Mellitus.” Archives of Medical Science, vol. 5, 2013, pp. 936–43, https://doi.org/10.5114/aoms.2013.34991. ?
Status
In-stock
Other products related to repaglinide
Name of Impurity | Catalogue No. | |
---|---|---|
Repaglinide EP Impurity A | VL3320001 | View CAS 220438-80-2 |
Repaglinide EP Impurity B | VL3320002 | View CAS 99469-99-5 |
Repaglinide EP Impurity C (Glutamate Salt) | VL3320010 | View CAS 219921-94-5 |
Repaglinide EP Impurity D | VL3320004 | View CAS 147770-06-7 |
Repaglinide EP Impurity E | VL3320006 | View CAS 147852-26-4 |
Repaglinide Ethyl ester (As per USP) | VL3320011 | View |
Repaglinide Impurity 1 | VE008525 | View |
Repaglinide Related Compound C | VL3320005 | View CAS 1803084-79-8 |
Repaglinide Related Compound E | VL3320012 | View CAS 147852-26-4 |